Anebulo Pharmaceuticals Inc (ANEB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 06/30
| 09-2024 | 06-2024 | 03-2024 | 12-2023 | 09-2023 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -2,201 | -8,202 | -6,852 | -5,198 | -2,481 |
| Depreciation Amortization | 60 | 151 | 92 | 32 | N/A |
| Accounts receivable | -245 | N/A | N/A | N/A | N/A |
| Accounts payable and accrued liabilities | 96 | -378 | -150 | -216 | 31 |
| Other Working Capital | 164 | -799 | 141 | 196 | -457 |
| Other Operating Activity | 437 | 1,137 | 731 | 646 | 179 |
| Operating Cash Flow | $-1,690 | $-8,091 | $-6,038 | $-4,541 | $-2,727 |
| Cash Flows From Investing Activities | |||||
| Investing Cash Flow | $N/A | $N/A | $N/A | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Other Financing Activity | 0 | -62 | -62 | -62 | 0 |
| Financing Cash Flow | $N/A | $-62 | $-62 | $-62 | $N/A |
| Beginning Cash Position | 3,094 | 11,247 | 11,247 | 11,247 | 11,247 |
| End Cash Position | 1,404 | 3,094 | 5,147 | 6,645 | 8,521 |
| Net Cash Flow | $-1,690 | $-8,153 | $-6,100 | $-4,603 | $-2,727 |
| Free Cash Flow | |||||
| Operating Cash Flow | -1,690 | -8,091 | -6,038 | -4,541 | -2,727 |
| Free Cash Flow | -1,690 | -8,091 | -6,038 | -4,541 | -2,727 |